Alzamend Neuro reports early brain study data for AL001 compound
Go back to Alzamend Neuro reports early brain study data for AL001 compound| (NASDAQ: ALZN) | Delayed: 1.37 +0.15 (12.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.22 | 52 Week High | $ | |||
| Open | $1.18 | 52 Week Low | $ | |||
| Day High | $1.37 | P/E | N/A | |||
| Day Low | $1.18 | EPS | $ | |||
| Volume | 358,002 | |||||

